On May 11, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s SARS-CoV-2…
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…
On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
On May 11, 2020, Arbutus Biopharma announced the establishment of a new research initiative focused on the identification…
On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…
On May 8, 2020, Abbott announced new research, published in the Journal of Clinical Microbiology, which found that…
On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
On May 6, 2020, bioMerieux announced performance validation and the launch of VIDAS anti-SARS-CoV-2 serology tests to detect…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…